Back to Companies
Apellis Pharmaceuticals, Inc.
APLSCIK: 0001492422
Recent Form 4 activity at Apellis Pharmaceuticals, Inc. (APLS) spans 50 filings across 19 insiders (all of them on the sell side). Purchases total $0 against $2.4M in sales — heavily weighted toward selling, for net sales of $2.4M. Francois Cedric is the most active by dollar volume, and the single largest transaction was $49.7M by Francois Cedric. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$162.0M
Purchases
$0
Sales
$2.4M
Unique Insiders
19
Recent Insider Trades
50 loaded
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Insider | Grant | $12.6M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Chopas James George | Insider | Grant | $4.0M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Walbert Keli | Insider | Disposed | $876.7K |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Francois Cedric | Insider | Grant | $49.7M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Insider | Grant | $2.6M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Insider | Disposed | $4.3M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | O'Brien Stephanie Monaghan | Insider | Disposed | $6.2M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | WHEELER CRAIG A | Insider | Disposed | $882.0K |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | FONTEYNE PAUL R. | Insider | Disposed | $4.4M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Baumal Caroline | Insider | Grant | $6.5M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Machiels Alec | Insider | Disposed | $6.2M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Watson David O. | Insider | Grant | $11.6M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Insider | Grant | $17.3M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Dolsten Mikael | Insider | Disposed | $505.9K |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Insider | Grant | $8.5M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Boucher Kelley | Insider | Grant | $3.2M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Insider | Grant | $13.6M |
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Chan Gerald | Insider | Disposed | $6.2M |
| May 1 | APLS Apellis Pharmaceuticals, Inc. | Baumal Caroline | Chief Medical Officer | Gift | $0 |
| Apr 20 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Insider | Gift | $0 |
| Apr 8 | APLS Apellis Pharmaceuticals, Inc. | O'Brien Stephanie Monaghan | Director | Other | $0 |
| Apr 6 | APLS Apellis Pharmaceuticals, Inc. | BIOGEN INC. | Insider | Other | $0 |
| Mar 13 | APLS Apellis Pharmaceuticals, Inc. | Francois Cedric | Insider | Gift | $0 |
| Feb 13 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $8.2K |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Grant | $0 |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Chief Research and Development | Grant | $0 |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Grant | $0 |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Grant | $0 |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $223.9K |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $73.4K |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer, Director | Sell | $591.8K |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $168.1K |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sell | $129.0K |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Sell | $170.5K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Baumal Caroline | Chief Medical Officer | Sell | $37.3K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer, Director | Sell | $161.9K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Sell | $49.0K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $26.4K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $57.2K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sell | $18.0K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $43.6K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Nicholson Nur | Chief Technical Officer | Sell | $58.1K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sell | $50.5K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | $39.5K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer, Director | Sell | $226.0K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Sell | $128.2K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Chopas James George | VP/Chief Accounting Officer | Sell | $19.4K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $85.6K |
| Jan 9 | APLS Apellis Pharmaceuticals, Inc. | Watson David O. | General Counsel | Exercise | $26.6K |
| Jan 5 | APLS Apellis Pharmaceuticals, Inc. | Dunlop A. Sinclair | Director | Grant | $368.9K |
50 filings+